Trulieve Cannabis Corp. (CSE: TRUL) (OTCMKTS: TCNNF) recently went public via a reverse merger with schyan exploration. The stock trades as TRUL in Canada and TCNNF in the US. Trulieve Cannabis is a really exciting Company and it has quickly attracted a growing shareholder base who believes this one goes much higher.

Trulieve is quickly establishing itself as a major player in the booming cannabis space responsible for many, many huge recent winners. The sector is on fire as we near legal recreational cannabis in Canada on October 17. The global legal marijuana market is expected to reach USD 146.4 billion by end of 2025, according to a new report by Grand View Research, Inc. According to a report from BDS Analytics and The Arcview Group, Florida’s medical cannabis market is expected to grow rapidly and exceed $1 billion by 2020.

Trulieve Cannabis Corp. (CSE: TRUL) (OTCMKTS: TCNNF) is a Quincy-based, vertically integrated “seed to sale” company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. The Company employs over 800 people and is committed to providing patients a consistent and welcoming retail experience across Trulieve branded stores.

As a vertically integrated company with a patient-first mantra, Trulieve has developed a suite of Trulieve branded products with over 80 SKUs including flower pods for vaporizing, concentrates, topicals, capsules, tinctures, and vape cartridges.

Trulieve currently has 20 retail locations open and several more in the works. The Company has been aggressive about opening dispensaries, being the first to open one in the state earlier this year, and expanding its cannabis product line. The Company has over 450,000 square feet of cultivation facilities with a further 95,000 square feet to be added in 2018.

Trulieve currently has over 100,000 patients and 1,600 qualifying physicians, and they offer qualified patients the largest selection of low- and high-THC products in the state with various delivery methods, including vaporizers, flower for vaporizing, tinctures, syringes, capsules, a nasal spray and a topical cream. There are also over 90 varieties of product available.

Trulieve US operates a “good manufacturing practice” certified processing facility that produces 90 different private label, medical grade cannabis products that are sold through 17 company-owned dispensaries. n addition, Trulieve is focused on leveraging its manufacturing and retail expertise to expand into other states in the United States.

To Find out the inside Scoop on Trulieve Cannabis Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

The Company is led by Kim Rivers, a Florida native who began her career as an attorney and decided to try her hand in real estate just as the housing market started to crash. 3 years later she is running a medical marijuana start-up as its CEO.

On September 24 Trulieve Cannabis announced its financial results for the three and six-month periods ended June 30, 2018. The Company’s second quarter 2018 financial statements have been filed as part of its listing statement with the Canadian Securities Exchange (“CSE”). This news release is not in any way a substitute for reading those financial statements, including the notes to the financial statements.

Q2 2018 Highlights included 16 dispensaries in operation, 83,000 active unique patients. revenue grew from $15.2 million in Q1 2018 to $23.3 million in Q2 2018 and EBITDA1 increased from $11.2 million in Q1 2018 to $14.3 million in Q2 2018

Trulieve CEO Kim Rivers stated “The second quarter of 2018 demonstrated our ability to scale our business profitably with growth in dispensaries and patients served driving growth in revenue and EBITDA1. This momentum is continuing in the current quarter and we expect strong results throughout 2018.”

Trulieve Cannabis is an exciting Company and the first and largest fully licensed medical cannabis company in the State of Florida. The Company currently has 20 retail locations open and several more in the works as well as over 450,000 square feet of cultivation facilities with a further 95,000 square feet to be added in 2018. With over 100,000 patients and 1,600 qualifying physicians Trulieve is the early leader in the Florida medical cannabis market which is expected to grow rapidly and exceed $1 billion by 2020. We will be updating on Trulieve when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with Trulieve.

Disclosure: we hold no position in Trulieve either long or short and we have not been compensated for this article.